Clinical Trial Update: A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the DPP-4 inhibitor RO4876904 in patients with Type 2 diabetes mellitus has completed, sponsored by Hoffmann-La Roche.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO4876904 (DPP-4 inhibitor RO4876904)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED